Bioxytran, Inc. is a U.S.-based clinical-stage biotechnology company focused on developing innovative therapies for hypoxia-related conditions, viral infections, and degenerative diseases. The company leverages advanced carbohydrate-based drug design and galectin inhibitor technology to create treatments aimed at stroke, wound healing, and infectious diseases like COVID-19. Its pipeline includes promising drug candidates such as oxygen-carrying therapeutics, antiviral agents and anti-metastasis for cancer designed to address critical unmet medical needs and improve patient outcomes.
-
1 Beiträge
-
1 Fotos
-
0 Videos
-
Lebt in Needham
-
Von Needham
-
Follower 0 Menschen
Suche
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
